IL38339A - 5,10-epoxy-19-nor steroids and process for their preparation - Google Patents

5,10-epoxy-19-nor steroids and process for their preparation

Info

Publication number
IL38339A
IL38339A IL38339A IL3833968A IL38339A IL 38339 A IL38339 A IL 38339A IL 38339 A IL38339 A IL 38339A IL 3833968 A IL3833968 A IL 3833968A IL 38339 A IL38339 A IL 38339A
Authority
IL
Israel
Prior art keywords
group
carbon
steroids
chosen
process according
Prior art date
Application number
IL38339A
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of IL38339A publication Critical patent/IL38339A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Description

NOR AND QCESS FOR THEIR present invention relates to a novel process for the preparation of of and to the novel compounds thus The novel epoxides are valuable intermediates in steroid and of especially in the or alkenyl steroids described and claimed in the copending patent application from the present patent application has been divided process of the invention comprises the epoxidation of steroids by the action of peracids with preponderant formation of the corresponding bitertiary epoxides at The result could not be foreseen with certainty because a priori it was not obvious that there would be formed in a preponderant manner the rather than the The invention has as object a process for preparing the bitertiary epoxides at of characterized essentially in that one 9 steroids to the action of obtains a mixture of corresponding and 5 which one if need into the desired epoxide and The said process is applied more particularly to the steroids which carry at the a lower alkyl radical having 1 to 6 carbon the said steroids able to carry on the carbon at the groups such cyclic or or a hydroxy and on the carbon at the groups such as Epoxida One dissolves 3 of i in French Patent in 13 of methylene adds then introduces at in about 40 minutes a concentrated solution of perphthalic acid i ether One agitates overnight then pours the mixture into i aqueous solution of sodium extracts with methylene washes the organic solution with salt j dries and distils to One obtains j i of a mixture of and used as it is the ext As as is two products are not described in the Reduction of the ketone at i One puts 1 of the mixture obtained above j suspension in 10 of adds at of sodium One agitates for minutes under dilutes with water admixed with of acetic extracts with methylene washes the solution with an solution of sodium then with dries and distils to One obtains a mixture of j which one it is for the next stage of the As far as is two compounds are j described in r one sso g o 3 dimethoxy 17 oxo estra diene French Patent one cools to and in about a concentrated solution of perphthalic acid in ether One maintains overnight washes the filtrate with an solution sodium with salt dries on sulphate and distils to One pastes the residue in 8 of isopropyl adds 2 petroleum ether for 2 filters vacuo and washes the precipitate with an isopropyl ethe ether The isopropyl ether mother liquors are recovered with view to the later isolation of the The produc thus obtained is purified by dissolving in methylene then in isopropyl One obtains o as it is for the next The product is soluble in chloroform and it is soluble in isopropyl ether end spectrum at at far as io known this compound is not described triethylamine one obtains successively ι 188 of after crystallization in isopropyl melts at j i The product is soluble in it is insoluble in As far as is this is not described in the literature i 867 of crude pyl which one purifies by pasting in filterin and washing with cooled One obtains of product melting at soluble in methylene chloride and insoluble in far as is this compound is described j in the literature The starting product edio can be obtained in the ing wa ropyl Qne introduces 1 described in French Patent into 10 of One adds of acetic under agitation and and maintains at for 2 One then pours the solution into 150 of One leaves at rest for filters in washes and dries in one obtains of One takes reflux for 6 a mixture of Analysis spectrum λ at Inflexion at about 21 at λ at 280 19 As far as is this compound is not described in the literature and then of product which one dissolves in 80 of boiling isopropyl one filters and concentrates the filtrate to about 35 One for minutes and filters in One obtains 673 16 The product is soluble in chloroform and Found spectrum λ at 229 378 Inflexion at about 267 22 λ at 273 λ at 280 19 As far as is this compound is not described in literature Stage 1 introduces of in French Patent 1 into 226 of and of water and adds at and while agitating sodium maintains for under nitrogen at then allows to return to ambient One dilutes with of water and adds 3 of acetic One extracts with methylene washes the methylene i extracts with an aqueous solution of sodium bicarbonate and again with One dries on sodium sulphate and distils to The product thus obtained is pasted in the ethyl mixture then crystallized in ethyl acetate in the The mother liquors deriving from the pasting and the crystallization in ethyl acetate are distilled to One treats the ith 80 of pyridine and 40 acetic anhydride and leaves overnight under One decomposes the excess reagent by adding extracts with methylene washes the organic phase with with N hydrochloric an aqueous solution of sodium bicarbonate and finally with dries and distils to pastes the residue 60 of isopropyl ether at boiling pools and isolates a crude product which one recrystallizes by dissolving in of isopropyl ether the concentrates to 0 and obtains 12 of 1 As far as is compound is not described in the 2 One takes to reflux 1 hour under 12 of 5 of methanol and 29 of a solution of potassium One with water and the chloroform by of One leaves overnight then filters pin vacuo and washes with The product thus obtained is recrysfcallized in then in ethyl One obtains of estra j r C As far as is this compound is not described in the insufficientOCRQuality

Claims (1)

1. WHAT IS CLAIMED Process for preparing characterized in that one subjects a to the action of a and obtains a mixture of the and compounds of corresponding Λ nor which one if need into the desired and 5β Process according to Claim 1 characterized in that the lower alkyl radical at the contains 1 to 6 carbon Process according to Claims 1 and characterized in that the starting steroid carries on the carbon at the a substituent chosen from the group consisting of a a cyclic or the and on the carbon at the a substituent chosen from the group consisting of the keto acetyl the keto group of which has previously been blocked in the form of a Process according to Claims 1 and characterized in that the peracid used for the epoxidetion is chosen from the group consisting of perbenzoic performic acid and peracetic Process according to Claims 1 and 2 characterized in that the is effected in an organic solvent chosen from the group consisting of an aromatic a chlorinated solvent and an Process for preparing steroids substantially as hereinbefore described and with reference to any of the The steroids in which is found on the carbon at the a chosen from the group consisting of a cyclic or or a and on the carbon at the a acetyl keto group Of which has previousl been blocked in the or a or a keto acetoxygont 3 Box 33116 Attorneys for Applicant insufficientOCRQuality
IL38339A 1967-03-20 1968-03-05 5,10-epoxy-19-nor steroids and process for their preparation IL38339A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR99496 1967-03-20

Publications (1)

Publication Number Publication Date
IL38339A true IL38339A (en) 1973-04-30

Family

ID=8627214

Family Applications (3)

Application Number Title Priority Date Filing Date
IL29578A IL29578A (en) 1967-03-20 1968-03-05 Process for the introduction of hydrocarbon substituents at the 10-position of 19-nor steroid derivatives and novel compounds thus obtained
IL38339A IL38339A (en) 1967-03-20 1968-03-05 5,10-epoxy-19-nor steroids and process for their preparation
IL38339A IL38339A0 (en) 1967-03-20 1971-12-13 Process for the introduction of hydrocarbon substituents at the 10-position of 19-nor steroid derivatives and novel compounds thus obtained

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL29578A IL29578A (en) 1967-03-20 1968-03-05 Process for the introduction of hydrocarbon substituents at the 10-position of 19-nor steroid derivatives and novel compounds thus obtained

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL38339A IL38339A0 (en) 1967-03-20 1971-12-13 Process for the introduction of hydrocarbon substituents at the 10-position of 19-nor steroid derivatives and novel compounds thus obtained

Country Status (8)

Country Link
JP (1) JPS5021470B1 (en)
CH (1) CH492690A (en)
DE (1) DE1668652B2 (en)
DK (1) DK129197B (en)
FR (1) FR1550974A (en)
GB (2) GB1228212A (en)
IL (3) IL29578A (en)
NL (1) NL158505B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2213272B1 (en) * 1973-01-05 1977-07-22 Roussel Uclaf
DE3630030A1 (en) * 1986-09-01 1988-03-03 Schering Ag 13 (ALPHA) -ALKYLGONAN- (DELTA) (UP ARROW) 9 (UP ARROW) (UP ARROW) ((UP ARROW) (UP ARROW) 1 (UP ARROW) 1 (UP ARROW)) (UP ARROW) -5, 10-EPOXIDE
FR2854402B1 (en) 2003-04-29 2008-07-04 Aventis Pharma Sa NOVEL PROCESS AND INTERMEDIATES FOR PREPARING 19-NOR-STEROID COMPOUNDS

Also Published As

Publication number Publication date
CH492690A (en) 1970-06-30
JPS5021470B1 (en) 1975-07-23
NL158505B (en) 1978-11-15
DE1668652A1 (en) 1971-06-03
DK129197C (en) 1975-03-24
FR1550974A (en) 1968-12-27
DE1668652B2 (en) 1976-07-01
IL38339A0 (en) 1972-02-29
NL6803859A (en) 1968-09-23
IL29578A (en) 1973-04-30
GB1228211A (en) 1971-04-15
DK129197B (en) 1974-09-09
GB1228212A (en) 1971-04-15

Similar Documents

Publication Publication Date Title
IL28112A (en) 11beta-alkoxy-estra 1,3,5(10)-trienes and their preparation
DE1468950C3 (en) Process for the preparation of 3-0x0-4,9-11-triene steroids and some of these compounds
IL38339A (en) 5,10-epoxy-19-nor steroids and process for their preparation
US2668816A (en) Process for the preparation of 17, 20-hydroxyketones of the pregnane series and new and useful compounds of the said series
US3349083A (en) Process for the production of 6beta:19-oxido-steroids
US2662854A (en) Photochemical preparation of 17, 20-hydroxy-ketones of the pregnane series
DE1568308B2 (en) PROCESS FOR MANUFACTURING DELTA HIGH 4,9,11-TRIENES OF THE 19-NOR- ANDROSTAN SERIES, 17-OXYGENATED 3-OXO- 7 ALPHA-METHYL-DELTA HIGH 4,9,11-19 NOR- ANDROSTATRIENE AND PHARMACEUTICALS CONTAINING THESE PRODUCTS 3-OXO-7 ALPHA -METHYL-DELTA UP 5 (10), 9 (11) -19-NOR- ANDROSTADIENE
US2677695A (en) Process for preparing 17alpha-hydroxy 20-keto steroids
Keana et al. Synthesis of the ABC ring system of batrachotoxin and several related highly functionalized cholane derivatives
US2318105A (en) Hydrated acetylene derivatives of the cyclopentanopolyhydrophenanthrene series and process of preparing same
DE2439082A1 (en) 17 ALPHA-HYDROXY-1,3,5 (10), 15-OESTRATETRAENE AND THE METHOD OF MANUFACTURING IT
Agnello et al. A Stereospecific Synthesis of C-21-Methylated Corticosteroids1a, d
Angyal et al. 69. Cyclitols. Part VIII. Elimination of vicinal sulphonyloxy-groups by iodide ion
Wolff et al. The Synthesis of C-18 Functionalized Hormone Analogs. III. Synthesis of Aldosterone1a
US2673847A (en) Steroid epoxides
US2715621A (en) Steroids
US2832772A (en) 21-diazo-compounds for synthesizing steroids
US3176032A (en) 17alpha, 21-diacyloxy derivatives of 6alpha-methyl-delta1, 4-pregnadien-3, 20-dione and of 6alpha-methyl-delta4-pregnen-3, 20-dione
US3169958A (en) 3-oxygenated-5alpha-halogen-6beta:19-oxido-pregnanes
Brimacombe et al. Syntheses of 6-deoxy-3-O-methyl-D-gulose and 6-deoxy-3-O-methyl-L-mannose (L-acofriose)
US3138620A (en) Androstanone derivatives
US2773868A (en) Steroid ketal
DE1618875C3 (en) Process for the preparation of Salpha-halogen-öbeta-acyl-oxysteroids
US2944052A (en) Novel epoxy pregnanes
DE1568308C3 (en) 09/10/65 Switzerland 12624-65 Process for the production of delta high 4,9,11-trienes of the 19-norandrostan series, 17-oxygenated 3-oxo-7 alpha-methyl-delta high 4,9,11-19 and norandrostatrienes containing them pharmaceutical preparations and 3-oxo-7 alpha-methyl-delta to the power of 5 (10), 9 (11) -19-norandrostadienes